Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 367

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 367
---
1 par value. (M)Reflects exchange of Profusa’s Series C/C1 Convertible Preferred Stock for common stock of Profusa with $0.0001 par value. (N)Reflects conversion of Senior Notes and Senior Bridge Notes into 6,267,204shares of Profusa in accordance with their terms. (O)Reflects conversion of Junior Notes into 2,631,652shares of Profusa in accordance with their terms. (P)Reflects the impact of Maximum Redemption of 52,159 redeemable shares of NorthView, which reflects $1.25million remaining in trust under the Maximum Redemption scenario. (Q)Represents reclassification of Profusa’s transaction costs incurred in excess of proceeds received under the Maximum Redemptions scenario from additional paid -incapital to accumulated deficit. (R)Represents issuance of shares in New Profusa upon conversion of Northview’s convertible loan at the Closing of the Merger. (S)Reflects the elimination of gain from change in FV of Tasly Convertible Debt upon Merger and reduction of loan balance. (T)Represents the closing of the APAC Joint Venture and receipt of the remaining $4.1 million of transaction proceeds. As presented in the unaudited pro forma condensed combined financial information, in exchange for the license, the JV would pay Profusa an upfront fee of $6 million, of which $1.6 million has been received as a loan in advance of the contract execution. As such, the remaining $4.1 is being reflected as a pro forma adjustment on the balance sheet as of December31, 2024. Although the accounting treatment has not yet been determined, Profusa preliminarily expects this JV to be treated as an equity method investment. A total of $6 million will be paid to Profusa for a 60% ownership in the JV, assuming a fair value of $10 million for the license transferred, and the Company will retain a 40% interest in the JV. All accounting conclusions will be finalized after the closing of the transaction and the finalization of the JV valuation. For the purpose of the preliminary pro forma information, the Company has accounted for the transaction as if it paid $4 million in noncash consideration (representing the FV of its retained 40% of the Licensed Products contributed to the JV) as its Investment in the JV and Equity Interest in the JV. In addition, the Company recorded the sale of 60% of the JV and recognized